Fierce Pharma

MAY 21, 2024

A decade ago, with AstraZeneca in decline and some investors urging the drugmaker to sell out to Pfizer, new CEO Pascal Soriot presented an audacious plan to hike revenue to $45 billion by 2023. | After AstraZeneca achieved Pascal Soriot's ambitious $45-billion-by-2023 revenue goal, the CEO is thinking big again. On Tuesday morning, AZ unveiled its new plan to swell its revenue to $80 billion by 2030.

292

292

Clarivate

MAY 21, 2024

We have released the first version of the Clarivate Academic AI Platform, serving our suite of AI-powered Research Assistants. Discover how it is going to help address the needs of students, researchers and librarians for trusted AI. At Clarivate TM , we understand the transformative power of artificial intelligence (AI) in the academic realm and the imperative to introduce AI thoughtfully and responsibly into research, teaching and learning environments.

Government 129

Government Management Ethics Specialization 129

Fierce Pharma

MAY 21, 2024

Following last year’s hard-won ulcerative colitis nod for Eli Lilly’s Omvoh, also known as mirikizumab, the Indianapolis-based drugmaker is padding the case for its antibody’s next potential immuno | Following last year’s hard-won ulcerative colitis nod for Eli Lilly’s Omvoh, also known as mirikizumab, the Indianapolis-based drugmaker is padding the case for its antibody’s next potential immunology approval.

239

239

MedCity News

MAY 21, 2024

Employers need healthcare data in order to make decisions, but the data isn’t always easy to get, experts said on a panel at MedCity INVEST. The post Why Healthcare Data Is Vital for Employers appeared first on MedCity News.

Healthcare 127

Healthcare Healthcare 127

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MAY 21, 2024

As Incyte Corporation continues its growth momentum thanks to JAK inhibitors Jakafi and Opzelura, the company is bringing its U.S. | Incyte revealed plans to purchase buildings at 1100 North King Street and 1100 North French street in downtown Wilmington, Delaware, where the company got its start back in 2002.

Medical 226

Medical 226

MedCity News

MAY 21, 2024

The NIH’s SEED office formed to help startups leverage government’s funding programs. Chris Sasiela, director of the SEED office, discussed these programs during the MedCity News INVEST Conference in Chicago. The post 5 Things to Know About How NIH’s SEED Can Help Life Science Startups Grow appeared first on MedCity News.

Biopharma 120

Biopharma 120

MedCity News

MAY 21, 2024

During a panel at MedCity News’ INVEST conference, venture capitalists shared some of their takes on today’s healthcare funding landscape — including their thoughts on AI and the industry’s slower investment pace. The post 4 Things Digital Health Investors Need To Get Off Their Chest appeared first on MedCity News.

Healthcare 115

Healthcare Healthcare 115

pharmaphorum

MAY 21, 2024

FDA is asking artificial intelligence teams to develop a digital endpoint tool to study freezing of gait, a symptom of Parkinson’s that can have a serious impact on patients.

Competition 112

Competition FDA Patients 112

PM360

MAY 21, 2024

PM360’s Focus On section examines a specific area of the life sciences industry. In this issue, we take a closer look at the evolution of the Smart TV and the increase of streaming services and how they can benefit the pharma industry. From connecting with patients by interactive ads to dabbling into cross-platform integration, here is what our specialists had to say.

Media 105

Media Healthcare Healthcare Marketing 105

European Pharmaceutical Review

MAY 21, 2024

Initial data from a Phase III maintenance study of TREMFYA ® (guselkumab) has demonstrated promising remission rates obtained from a dual-acting monoclonal antibody given to ulcerative colitis (UC) patients. This data from Johnson & Johnson’s Phase III QUASAR study is being presented at Digestive Disease Week 2024 (Abstract #759). Achievement of clinical remission Fifty percent of patients with moderate to severe active ulcerative colitis given subcutaneous TREMFYA (guselkumab) 200mg every f

Patients 105

Patients Leads Pharmaceutical 105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

MAY 21, 2024

AstraZeneca CEO Pascal Soriot says group revenues can reach $80bn by 2030, fuelled by a pipeline that features 'many' potential $5bn-plus candidates.

114

114

Scott Burrows

MAY 21, 2024

In the world of motivational speaking, stories of triumph over adversity are not uncommon. But for me, the narrative goes beyond inspiration—it’s about embodying the very principles of vision, mindset, and grit that have shaped my journey. At the age of 19, a car accident left me with a broken neck and a daunting diagnosis of quadriplegia. But from the confines of a wheelchair, I refused to let my circumstances define me.

Management 98

Management Marketing 98

MedCity News

MAY 21, 2024

The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development. The post Importance of Patient Capital in Life Sciences appeared first on MedCity News.

Patients 101

Patients 101

pharmaphorum

MAY 21, 2024

Going against the advice of the CHMP, the EU has said that PTC Therapeutics’ Translarna therapy for Duchenne muscular dystrophy should stay on the market

Marketing 103

Marketing 103

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaVoice

MAY 21, 2024

These three U.S. cities are putting themselves on the biotech map as unsung hubs of the industry.

116

116

Pharmaceutical Commerce

MAY 21, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law offers his thoughts on the recent Federal Trade Commission (FTC) repeal of non-compete agreements, and how it could effect the pharma industry.

Pharma 81

Pharma 81

pharmaphorum

MAY 21, 2024

Digital investment in the pharma sector is continuing at a steady pace but could fall behind what is needed to deliver true transformation of their businesses.

Pharma 84

Pharma 84

Pharmaceutical Technology

MAY 21, 2024

Roche announced an FDA breakthrough therapy designation for its inavolisib/Ibrance combination therapy.

FDA 98

FDA 98

Advertisement

PharmaTimes

MAY 21, 2024

The network will support the development, evaluation and adoption of innovative health and care technology

Networking 89

Networking 89

PM360

MAY 21, 2024

A well-oiled modular content engine lets manufacturers engage customers and differentiate their product beyond the label. By Matthew Smith Over the past few years, the life sciences industry has seen an increase in ways to engage with customers at different touchpoints. During the COVID-19 pandemic, pharma organizations built new digital and virtual channels to communicate with healthcare providers (HCPs) outside of their offices.

Manufacturing 59

Manufacturing Marketing Distribution Pharma 59

PharmaTimes

MAY 21, 2024

The funding aims to reduce health inequalities in these groups and save more lives

88

88

Pharmaceutical Commerce

MAY 21, 2024

The latest news for pharma industry insiders.

Pharma 99

Pharma 99

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Scott’s Directories

MAY 21, 2024

The landscape of healthcare is constantly evolving. As the demand for accessible, high-quality care grows, new approaches and roles are emerging to meet these critical needs. Nurse practitioners (NPs) have become a cornerstone of this transformation, providing patients with comprehensive, personalized care. However, finding qualified NPs can sometimes feel like a daunting task.

Healthcare 52

Healthcare Healthcare Education Medical 52

PM360

MAY 21, 2024

EVERSANA and MyHealthTeam collaborate to help patients connect more quickly on social media regarding diagnosis and treatment. EVERSANA and MyHealthTeam Collaborate to Launch Direct-to-Patient Solution EVERSANA and MyHealthTeam announced that they have joined forces to help life sciences companies use the power of Artificial Intelligence (AI) and accelerate the time to diagnosis and treatment for millions of patients all over the world.

Media 52

Media Patients Medical Engineering 52

PharmExec

MAY 21, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Tala Fakhouri, at Financial Times’ US Pharma and Biotech Summit, Tala Fakhouri, Associate Director for Policy Analysis, FDA, discusses whether the FDA plans on restricting the use of AI and what the future could look like when it comes to machine learning.

FDA 52

FDA Pharma 52

PM360

MAY 21, 2024

Gender imbalance was so ingrained in me as I grew up that, even as a woman, I have at times in my career been gender- blind. I was lucky enough to enter academia with a number of women colleagues. It was only later in my career that I started noticing the gender gap in the pharma industry. Minding the Gap In 2012, I was invited to a life science and pharma event in London as part of the Olympics.

Pharma 52

Pharma Pharmaceutical 52

Advertisement

Distribution

Clarivate

MAY 21, 2024

With the goal of cancer treatment generally to extend a patient’s life for a meaningful length of time, overall survival (OS) is widely considered the ‘gold standard’ endpoint in oncology clinical trials [1] [2]. However, alternative oncology-relevant endpoints beyond OS offer great potential for supporting faster and more efficient access to therapies.

Food and Drug Administration 52

Food and Drug Administration Patients Consulting Marketing 52

PM360

MAY 21, 2024

From 19th century fiction like Pinocchio to modern science fiction like Star Trek, Artificial Intelligence (AI) has intrigued us with existential dilemmas and life-changing potential. It is unsurprising then that AI’s arrival has impacted Life Sciences so profoundly. AI has driven major advances across the Life Sciences value chain from molecule discovery to clinical trials to manufacturing.

Medical 52

Medical Patients Insurance Manufacturing 52

Scott Burrows

MAY 21, 2024

In the world of keynote motivational speakers, there are those who inspire with words, and then there are those who inspire with their very existence. My journey, marked by triumph over adversity, serves as a testament to the power of the human spirit and the principles that guide us through life’s toughest challenges: vision, mindset, and grit.

Safety 52

Safety Specialization Healthcare Healthcare 52

PM360

MAY 21, 2024

Manufacturer assistance programs are designed to make treatments more affordable, yet only about 10% of these dollars are used by patients. While there are several factors influencing why these programs are underutilized, fixing issues with cumbersome technology and workflows can improve the experience. The cost of filling a prescription can keep 21% of patients from getting an Rx, and one in ten patients will modify their treatment plan because of cost, according to recent polling data from KFF

Electronics 52

Electronics Prescription Pharmaceutical manufacturing Patients 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales